Target intelligence / Profile preview

MicroRNA 4438 (MIR4438)

Target
MIR4438
Molecular classification
MicroRNA, Non-coding RNA, Gene regulator
01

Overview

MicroRNA 4438 is a predicted human microRNA gene producing a short non-coding RNA molecule involved in gene regulatory processes. MicroRNAs are functionally loaded into RNA-induced silencing complexes (RISC) and mediate post-transcriptional gene silencing by binding to target messenger RNAs with complementary sequences, resulting in their degradation or translational inhibition. MicroRNAs broadly influence cell differentiation, proliferation, apoptosis, and immune response through their regulation of multiple gene targets, and are studied as functional biomarkers in disease, especially cancer. For MIR4438, no disease-specific role, biomarker application, or drug interaction has been documented in current public literature. If you need additional details about experimentally validated functions, disease roles, or therapeutic targeting for MIR4438 specifically, current research and databases do not indicate established roles. Most scientific focus on microRNA therapeutics, disease classification, and mechanisms involves families or clusters with substantial supporting data.

Other names
MIR4438hsa-mir-4438microRNA 4438
02

Mechanism of action

Not applicable for drugs, as no drug interaction is reported for MIR4438. General mechanism for microRNAs: binding to complementary sequences in target mRNAs, leading to degradation or inhibition of translation.

03

Biological functions

Gene silencingPost-transcriptional regulation of gene expressionRNA interference
04

Disease associations

No disease associations are documented for MIR4438 itself.MicroRNAs in general are linked to cancer, cardiovascular disease, neurodegeneration, and infection.
05

Safety considerations

None documented for MIR4438.General challenges for microRNA-based therapies include off-target effects, delivery, and specificity.
06

Biomarkers

Not used as a biomarker for patient selection or efficacy monitoring to date.Many other microRNAs are established biomarkers in various cancer subtyping and prognosis.

Beyond the preview

Go deeper on MicroRNA 4438 (MIR4438).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4438 (MIR4438).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call